ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures
Clinical trial NCT05481905 · WITHDRAWN
Trial details
- NCT number
- NCT05481905
- Sponsor
- Engrail Therapeutics INC
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.